Posaconazole for the management of mucosal candidiasis

ISSN： 1746-0913

Source： Future Microbiology, Vol.2, Iss.3, 2007-06, pp. : 245-256

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Posaconazole: a next-generation triazole antifungal

By Farowski Fedja Vehreschild Jörg J Cornely Oliver A

Future Microbiology, Vol. 2, Iss. 3, 2007-06 ,pp. : 231-243

Future Medicine

Access to resources Recommend Favorite

Mucormycosis treated with posaconazole: review of 96 case reports

By Vehreschild Joerg J.

Critical Reviews in Microbiology, Vol. 39, Iss. 3, 2013-08 ,pp. : 310-324

Informa Healthcare

Access to resources Recommend Favorite

Low prevalence of genital candidiasis in children

By Banerjee K. Curtis E. San Lazaro C. Graham J.

European Journal of Clinical Microbiology and Infectious Diseases, Vol. 23, Iss. 9, 2004-09 ,pp. : 696-698

Springer Publishing Company

Access to resources Recommend Favorite

R.A. Calderone, ed. Candida and Candidiasis.

By White Theodore

Mycopathologia, Vol. 157, Iss. 4, 2004-05 ,pp. : 389-390

Springer Publishing Company

Access to resources Recommend Favorite